Stay updated on Abemaciclib Combinations in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Abemaciclib Combinations in Pancreatic Cancer Clinical Trial page.

Latest updates to the Abemaciclib Combinations in Pancreatic Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedPubMed publications note updated to indicate auto-filling from PubMed, and the page revision is updated to v3.3.2.SummaryDifference0.1%

- Check27 days agoChange DetectedDeleted the government funding operating status notice from the page; all other study content remains unchanged.SummaryDifference0.3%

- Check35 days agoChange DetectedThe Taiwan location entry in the Locations section was renamed from 'Tainan City, Taiwan, 70403' to 'Tainan, Taiwan, 70403'.SummaryDifference0.0%

- Check49 days agoChange DetectedCore study details, eligibility criteria, interventions, and primary outcomes appear unchanged between the two screenshots, with no new critical information introduced. The page layout and navigation look consistent with the prior version.SummaryDifference0.3%

- Check70 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%

- Check78 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.0%

Stay in the know with updates to Abemaciclib Combinations in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abemaciclib Combinations in Pancreatic Cancer Clinical Trial page.